Among these, FKBP5 and PSMD8 polymorphisms demonstrated measurable effects on ICS efficacy, while a large-scale study identified a novel variant (rs111720447) near the glucocorticoid receptor gene, which was significantly correlated with ICS response in COPD patients. This evidence concerns the gene FKBP5 and chronic obstructive pulmonary disease.